Resource Center for HIV+ patients

Volunteers needed for Emory HIV/AIDS Clinical Trials at Grady

Study ACTG 5240: HPV/GARDASIL Study
HIV positive female volunteers, age 18-45, are needed to participate in a research study that will determine the effectiveness, safety and tolerability of the HPV vaccine GARDASIL in HIV-infected women.

This is a 72 week study at the Ponce Center in Midtown. Must be on a stable HAART regimen for at least 12 weeks prior to study entry. Please contact Carolina Ibarra at 404.616.6333 to learn if you are eligible to become a participant. Compensation will be provided for time and travel once enrolled in the study.

Study ACTG 5235: HIV Associated Memory Problems
HIV positive male and female volunteers are needed to participate in a research study at Emory University that will determine if treating cognitive impairment, dementia and/or memory problems with Minocycline will better brain function in HIV positive patients.

This is a 24-48 week study at the Ponce Center in Midtown. Patient must be on a stable ART for 16 weeks. Please contact Carolina Ibarra at 404.616.6333 to learn if you are eligible to become a participant. Compensation will be provided for time and travel once enrolled in the study.

Study ACTG 5241: OPTIONS Study
HIV positive male and female volunteers whose medicine is no longer working are needed to participate in a research study at Emory University. Patients must currently be on a protease inhibitor-containing regimen, have a viral load greater than 1,000 and are resistant to or have received multiple types of HIV medicines. To be eligible, patient must have never received an integrase inhibitor.

This study will last 2-14 months. Not all drugs will be provided by the study. Please contact Carolina Ibarra at 404.616.6333 for more information and to learn if you qualify. Compensation will be provided for time and travel once enrolled in the study.

For studies at Grady's Ponce de Leon Center

341 Ponce De Leon Ave NE
Atlanta, GA 30308

Phone: 404.616.6313 to speak with a social worker on current AIDS Clinical Trial Group (ACTG) studies, plus other non-ACTG trials

Web: http://www.aactg.org/clinicaltrials_research.asp to view a list of current ACTG trials nationwide

Clinical trials that are currently open to enrollment are listed by category. Select from the categories (e.g. treatment-naive, immunity enhancers, side effects)that best describe the type of trial you are interested in. For each trial in the category, a link to more detailed information about the study will be provided on the next page.

ACTG trials currently at Grady include:

ACTG 5202: EFV or ATV with RTV combined with FTC/TDF or ABC/3TC in Naive Subjects. This study will be looking at first treatment combinations for HIV infection. This trial is for treatment-naive patients.

ACTG 5212: Palifermin for inadequate increase in CD4+ cells. The study will use three different doses of palifermin (recombinant human keratinocyte growth factor) to see which dose causes the greatest increase of CD4+ T cells (a measure of the immune system) to be produced from the thymus gland. This trial is for patients seeking an immunity enhancer study.

ACTG 5229: Uridine Supplementation in HIV Lipoatrophy. This is a study of the effects of uridine supplement (NucleomaxXr) on patients with body fat changes who are currently taking anti-HIV medications. This trial is for patients experiencing side effects from HIV medications.

For studies at Emory Crawford Long Hospital’s Department of Infectious Diseases

550 Peachtree St., Medical Office Tower, 7th floor
Atlanta, GA 30308

Phone: 404.686.2349 to speak with a research nurse about current enrolling studies
Web: Crawford Long trials listed on clinicaltrials.gov

For studies within the AIDS Research Consortium of Atlanta

131 Ponce de Leon Avenue, NE
Suite 130
Atlanta, Georgia 30308
Phone: 404.876.2317
Web:  http://www.arcatlanta.org

FAQs about clinical trials: Click here